2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Park, M. S. Articles by Devarajan, P. Search for Related Content PubMed PubMed Citation Articles by Park, M. S. Articles by Devarajan, P.

Cisplatin Induces Apoptosis in LLC-PK1 Cells via Activation of Mitochondrial Pathways

Moon Soo Park^*, Maryely De Leon^* and Prasad Devarajan^*

*Pediatric Nephrology, Children’s Hospital at Montefiore, Albert Einstein College of Medicine, New York, New York; Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

Correspondence to P. Devarajan, Children’s Kidney Center, 3326 Bainbridge Avenue, Bronx, NY 10467. Phone: 718-655-1120; Fax: 718-652-3136; E-mail: pdevaraj{at}aecom.yu.edu

ABSTRACT. Cisplatin, a commonly used chemotherapeutic agent, has a major limitation because of its nephrotoxicity. Recent studies have shown that cisplatin causes apoptotic cell death in renal tubule cells, but the underlying molecular mechanisms remain to be elucidated. In this study, cisplatin was found to induce apoptosis in a dose- and duration-dependent manner in cultured proximal tubule (LLC-PK1) cells, as evidenced by DNA laddering and TdT-mediated dUTP nick end-labeling assay. Pretreatment with the specific caspase 9 inhibitor LEHD-CHO completely prevented the apoptosis, whereas the caspase 8 inhibitor IETD-fmk had no effect. Furthermore, the activity of caspase 9 was upregulated about sixfold by cisplatin in a dose-dependent manner. These results implicated the caspase 9–dependent mitochondrial apoptotic pathways. Indeed, cisplatin triggered a duration-dependent translocation of cytochrome c from the mitochondria to the cytosol, by immunofluorescence and Western blots. Cisplatin treatment also resulted in the duration-dependent activation and mitochondrial translocation of the pro-apoptotic molecule Bax, by immunofluorescence. Finally, cisplatin induced a duration-dependent onset of the mitochondrial permeability transition. Our results indicate that cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial signaling pathways. The sequence of events may be summarized as follows: activation of Bax induces mitochondrial permeability transition, leading to release of cytochrome c, activation of caspase 9, and entry into the execution phase of apoptosis. Inhibition of this specific pathway may provide a strategy to minimize cisplatin-induced nephrotoxicity.

This article has been cited by other articles:

				K. Bhatt, L. Feng, N. Pabla, K. Liu, S. Smith, and Z. Dong Effects of targeted Bcl-2 expression in mitochondria or endoplasmic reticulum on renal tubular cell apoptosis Am J Physiol Renal Physiol, March 1, 2008; 294(3): F499 - F507. [Abstract] [Full Text] [PDF]

				Q. Wei, G. Dong, T. Yang, J. Megyesi, P. M. Price, and Z. Dong Activation and involvement of p53 in cisplatin-induced nephrotoxicity Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1282 - F1291. [Abstract] [Full Text] [PDF]

				C. Yang, V. Kaushal, S. V. Shah, and G. P. Kaushal Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1710 - F1717. [Abstract] [Full Text] [PDF]

				M. Jiang, N. Pabla, R. F. Murphy, T. Yang, X.-M. Yin, K. Degenhardt, E. White, and Z. Dong Nutlin-3 Protects Kidney Cells during Cisplatin Therapy by Suppressing Bax/Bak Activation J. Biol. Chem., January 26, 2007; 282(4): 2636 - 2645. [Abstract] [Full Text] [PDF]

				C. Brooks, J. Wang, T. Yang, and Z. Dong Characterization of cell clones isolated from hypoxia-selected renal proximal tubular cells Am J Physiol Renal Physiol, January 1, 2007; 292(1): F243 - F252. [Abstract] [Full Text] [PDF]

				J. Wang, N. Pabla, C.-Y. Wang, W. Wang, P. V. Schoenlein, and Z. Dong Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53 Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1300 - F1307. [Abstract] [Full Text] [PDF]

				J. Prakash, M. Sandovici, V. Saluja, M. Lacombe, R. Q. J. Schaapveld, M. H. de Borst, H. van Goor, R. H. Henning, J. H. Proost, F. Moolenaar, et al. Intracellular Delivery of the p38 Mitogen-Activated Protein Kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in Renal Tubular Cells: A Novel Strategy to Treat Renal Fibrosis J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 8 - 19. [Abstract] [Full Text] [PDF]

				Z. Yang, L. M. Schumaker, M. J. Egorin, E. G. Zuhowski, Z. Guo, and K. J. Cullen Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis. Clin. Cancer Res., October 1, 2006; 12(19): 5817 - 5825. [Abstract] [Full Text] [PDF]

				J. Wang, M. P. Biju, M.-H. Wang, V. H. Haase, and Z. Dong Cytoprotective Effects of Hypoxia against Cisplatin-Induced Tubular Cell Apoptosis: Involvement of Mitochondrial Inhibition and p53 Suppression J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1875 - 1885. [Abstract] [Full Text] [PDF]

				T. Eichler, Q. Ma, C. Kelly, J. Mishra, S. Parikh, R. F. Ransom, P. Devarajan, and W. E. Smoyer Single and Combination Toxic Metal Exposures Induce Apoptosis in Cultured Murine Podocytes Exclusively via the Extrinsic Caspase 8 Pathway Toxicol. Sci., April 1, 2006; 90(2): 392 - 399. [Abstract] [Full Text] [PDF]

				W. Qian, M. Nishikawa, A. Md. Haque, M. Hirose, M. Mashimo, E. Sato, and M. Inoue Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1466 - C1475. [Abstract] [Full Text] [PDF]

				T. Tanaka, I. Kojima, T. Ohse, R. Inagi, T. Miyata, J. R. Ingelfinger, T. Fujita, and M. Nangaku Hypoxia-inducible factor modulates tubular cell survival in cisplatin nephrotoxicity Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1123 - F1133. [Abstract] [Full Text] [PDF]

				R. Seth, C. Yang, V. Kaushal, S. V. Shah, and G. P. Kaushal p53-dependent Caspase-2 Activation in Mitochondrial Release of Apoptosis-inducing Factor and Its Role in Renal Tubular Epithelial Cell Injury J. Biol. Chem., September 2, 2005; 280(35): 31230 - 31239. [Abstract] [Full Text] [PDF]

				F. Yu, J. Megyesi, R. L. Safirstein, and P. M. Price Identification of the functional domain of p21WAF1/CIP1 that protects cells from cisplatin cytotoxicity Am J Physiol Renal Physiol, September 1, 2005; 289(3): F514 - F520. [Abstract] [Full Text] [PDF]

				H. Liu and R. Baliga Endoplasmic Reticulum Stress-Associated Caspase 12 Mediates Cisplatin-Induced LLC-PK1 Cell Apoptosis J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1985 - 1992. [Abstract] [Full Text] [PDF]

				E. Erkan, C. D. Garcia, L. T. Patterson, J. Mishra, M. M. Mitsnefes, F. J. Kaskel, and P. Devarajan Induction of Renal Tubular Cell Apoptosis in Focal Segmental Glomerulosclerosis: Roles of Proteinuria and Fas-Dependent Pathways J. Am. Soc. Nephrol., February 1, 2005; 16(2): 398 - 407. [Abstract] [Full Text] [PDF]

				M. Jiang, X. Yi, S. Hsu, C.-Y. Wang, and Z. Dong Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1140 - F1147. [Abstract] [Full Text] [PDF]

				K. J. Kelly, T. A. Sutton, N. Weathered, N. Ray, E. J. Caldwell, Z. Plotkin, and P. C. Dagher Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury Am J Physiol Renal Physiol, October 1, 2004; 287(4): F760 - F766. [Abstract] [Full Text] [PDF]

				P. M. Price, R. L. Safirstein, and J. Megyesi Protection of renal cells from cisplatin toxicity by cell cycle inhibitors Am J Physiol Renal Physiol, February 1, 2004; 286(2): F378 - F384. [Abstract] [Full Text] [PDF]

				K. Tsuruya, M. Tokumoto, T. Ninomiya, M. Hirakawa, K. Masutani, M. Taniguchi, K. Fukuda, H. Kanai, H. Hirakata, and M. Iida Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways Am J Physiol Renal Physiol, August 1, 2003; 285(2): F208 - F218. [Abstract] [Full Text] [PDF]

				M. Satoh, N. Kashihara, S. Fujimoto, H. Horike, T. Tokura, T. Namikoshi, T. Sasaki, and H. Makino A Novel Free Radical Scavenger, Edarabone, Protects Against Cisplatin-Induced Acute Renal Damage in Vitro and in Vivo J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1183 - 1190. [Abstract] [Full Text] [PDF]

				D. M. Townsend, M. Deng, L. Zhang, M. G. Lapus, and M. H. Hanigan Metabolism of Cisplatin to a Nephrotoxin in Proximal Tubule Cells J. Am. Soc. Nephrol., January 1, 2003; 14(1): 1 - 10. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673